U.S. Healthcare Services Stock News

What Lazard’s board changes mean for shareholders Lazard (LAZ) is moving from a staggered, multi year board structure to annual director elections. This governance shift could change how quickly shareholders influence the company after a mixed start to the year. See our latest analysis for Lazard. The governance change comes after a mixed few months for the stock, with the share price down 9.02% over 90 days and 3.22% year to date. However, the 3 year total shareholder return is 92.91%,...

Earlier in May 2026, Recursion Pharmaceuticals reported first-quarter revenue of US$6.5 million, a reduced net loss, and confirmed that its cash and cash equivalents are expected to support operations into early 2028 while advancing multiple clinical programs, including REC-4881, REC-1245, and REC-4539. A particularly interesting development is the Phase 2 efficacy signal for REC-4881 in familial adenomatous polyposis, which underscores how Recursion’s AI-native discovery platform is...

Enterprise Products Partners at a glance Enterprise Products Partners (EPD) remains in focus for income oriented investors, with the stock recently closing at $37.99 and the partnership generating revenue of $51.57b and net income of $5.84b. See our latest analysis for Enterprise Products Partners. Recent trading has been a little softer, with the share price down 3.6% over the past week, but the 18.1% year to date share price return and 5 year total shareholder return of 123.9% point to...

Wondering if Astec Industries at about US$51 per share is offering fair value right now, or if the recent price puts you at risk of overpaying? The stock is up 4.9% over the last 7 days and 14.4% year to date, although it is down 13.1% over the past month, with a 31.0% return over the last year and 44.0% over three years, while the five-year return shows a decline of 20.8%. Recent headlines around infrastructure spending, construction activity and heavy equipment demand have kept attention...

Insulet (NasdaqGS:PODD) issued a voluntary recall and medical device correction for certain Omnipod insulin Pods due to a manufacturing defect that can cause insulin under delivery. The action affects roughly 7 million Pods globally across the Omnipod 5, DASH, and Eros product lines. Insulet has received multiple reports of serious adverse events, including at least 24 severe cases requiring hospitalization, but no fatalities. The company is replacing affected Pods at no cost and does not...

Earlier this month, Quanta Services appointed Joseph Kim to its board, authorized a US$1.00 billion share repurchase program, and affirmed a quarterly dividend of US$0.11 per share payable on July 13, 2026. These moves combine fresh boardroom expertise in supply chain and logistics with capital returns that underscore management’s current priorities around buybacks and steady income. Next, we’ll examine how the new US$1.00 billion buyback authorization could influence Quanta’s existing...

Corbus Pharmaceuticals reported updated Phase 1/2 data for its Nectin-4 antibody‑drug conjugate CRB-701, showing robust activity and manageable safety in HPV‑driven oropharyngeal and cervical cancers, with plans to present the results at the ASCO 2026 meeting and to launch registrational trials in both indications. An interesting development is the FDA’s broad alignment on registrational trial designs targeting accelerated approval in second‑line oropharyngeal squamous cell carcinoma and...

Earlier this month, Argan Inc. reported fourth-quarter earnings of US$3.47 per share on revenue of US$262.1 million, exceeding Wall Street expectations. The earnings beat has prompted analysts to revisit their assumptions on Argan's earnings power and project execution ahead of its upcoming first-quarter 2026 results on June 4. Next, we'll examine how this earnings outperformance and raised analyst forecasts may reshape Argan's existing investment narrative around backlog and margins. We've...

Why Visa (V) is back on investors’ radar Visa (V) has attracted fresh attention after a recent shift in its share performance, with the stock up about 6% over the past month following earlier year to date and 1 year declines. See our latest analysis for Visa. Visa’s recent 5.8% 30 day share price return contrasts with a year to date decline of 5.45% and a 1 year total shareholder return that is down 8.21%, while the 3 year total shareholder return of 51.64% points to stronger longer term...

Wondering if Electronic Arts at around US$200 a share still offers value, or if most of the upside is already priced in. The stock recently closed at US$200.68, with returns that slipped 0.5% over 7 days, 0.9% over 30 days, and 1.8% year to date, while the 1 year return sits at 37.2% and the 3 and 5 year returns are 59.1% and 45.7%. Recent coverage has focused on Electronic Arts as a large player in gaming, with ongoing interest in its major franchises and live services. This helps explain...

Chesapeake Utilities overview and recent share performance Chesapeake Utilities (CPK) has drawn investor attention after recent share price moves, with the stock down about 1% over the past month and roughly 6% over the past 3 months. That has prompted closer scrutiny of its fundamentals and valuation. See our latest analysis for Chesapeake Utilities. At the current share price of $125.85, Chesapeake Utilities has seen some recent share price pressure, with the 90 day share price return down...

NextEra Energy and Dominion Energy (NYSE:D) have announced a definitive all stock agreement. The transaction would create the largest utility company in the U.S. if completed. The combined company is expected to operate with dual headquarters and a shared leadership structure. The deal would broaden reach across key power markets serving data centers and electrification trends. Dominion Energy enters this merger process with its shares at $67.2 and a return of 25.8% over the past year,...

Monro (MNRO) closed FY 2026 with fourth quarter revenue of US$273.8 million and a reported loss of US$6.6 million, equal to EPS of US$0.22, against a trailing twelve month profit of US$2.2 million and EPS of US$0.07 on revenue of US$1.2 billion. Over recent quarters the company has seen revenue move between US$305.8 million in Q3 FY 2025, US$301.0 million in Q1 FY 2026, US$288.9 million in Q2, US$293.4 million in Q3 and US$273.8 million in Q4. EPS has swung from a loss of US$0.72 in Q4 FY...

DICK'S Sporting Goods reported past first-quarter 2026 results with sales of US$5,164.50 million and net income of US$319.82 million, while slightly trimming its full-year earnings outlook despite topping earnings expectations. At the same time, the retailer continued returning cash to shareholders through nearly US$2.00 billion of share repurchases under a long-running buyback and introduced its new AI-powered Coach by DICK'S experience in the mobile app. Now, we’ll examine how the lowered...

Milk-Bone, owned by J. M. Smucker, has launched limited-edition Krypto Soft & Chewy Mini Treats. The release is tied to Warner Bros.' upcoming Supergirl film, expanding Milk-Bone's branded collaborations. The partnership is aimed at boosting brand visibility and engaging pet owners through an entertainment tie-in. For investors watching J. M. Smucker (NYSE:SJM), this Milk-Bone and Warner Bros. collaboration adds a fresh marketing angle to the pet treats portfolio. The stock recently closed...

Macy's (NYSE:M) recently reported a return to positive same-store sales growth. The company raised its full-year guidance following early progress from its store closure strategy. The update marks a change from a prior trend of declining same-store sales. Macy's, the US department store chain that also owns Bloomingdale's and Bluemercury, sits at the center of a retail sector still adjusting to e-commerce and changing shopper habits. Store closures have been a key focus across brick and...

Wondering whether Appian stock is offering value at its current price, or whether the risks outweigh the potential reward. The share price closed at US$21.64, with a small 1.4% gain over the last week and declines of 1.5% over the last month, 36.5% year to date and 30.7% over the past year. These moves may have shifted how investors view its risk and return profile. These moves sit against a backdrop of ongoing interest in low code and automation platforms. Investors are weighing long term...

Toast (TOST) is back in focus after announcing a partnership with ICC UK, where it will offer its restaurant technology platform to hospitality brands looking to expand between the UK and US. See our latest analysis for Toast. Despite the ICC UK partnership putting Toast back in the headlines, the stock has had a mixed run. The 1-day share price return of 5.06% contrasts with a year-to-date share price return down 27.98% and a 1-year total shareholder return down 41.83%, while the 3-year...

American Express (NYSE:AXP) has launched the ASID American Express Business Card in partnership with the American Society of Interior Designers. The new product targets interior designers and small design firms, focusing on their specific business spending and cash flow needs. The launch extends American Express business card offerings to a more specialized professional services segment. For American Express, this move fits within its broader role as a global payments and card services...

In May 2026, Starbucks announced and priced cash tender offers for several series of its outstanding senior notes, accepting early tenders up to an increased Aggregate Cap of US$1.30 billion and cancelling the purchased debt as part of its balance sheet management. The tender offers drew very strong bondholder participation, with valid tenders totaling about US$2.60 billion and triggering proration and early settlement mechanics that highlight investor interest in reshaping Starbucks’ debt...

Abbott Laboratories (NYSE:ABT) secured US and European clearance for its Ultreon 3.0 AI-powered coronary imaging platform, aimed at improving decision support during stent placement. The company received CE Mark in Europe for Libre Duo, a dual continuous glucose-ketone sensor designed for more comprehensive diabetes management. Abbott plans to present new evidence on its cancer diagnostics portfolio at the ASCO Annual Meeting, focusing on early detection and treatment guidance. Updated...

Coursera (COUR) has been drawing investor attention after recent trading, with the stock at US$5.32 and returns down over the past month and past 3 months. This has prompted closer scrutiny of its online education business. See our latest analysis for Coursera. Looking beyond the recent pullback, the stock’s 1-day and 7-day share price gains contrast with its weaker 30-day and year to date share price returns. At the same time, the 1-year and multi year total shareholder returns show a much...

Kingsoft Cloud Holdings (NasdaqGS:KC) opened Q1 2026 with revenue of C¥2.7b and a basic EPS loss of C¥1.13. Trailing twelve month figures show revenue of C¥10.3b and a cumulative EPS loss of C¥3.36. Over recent quarters the company has reported revenue of C¥2.2b in Q4 2024, C¥2.0b in Q1 2025 and C¥2.7b in Q1 2026. Quarterly EPS losses ranged from C¥0.80 in Q4 2024 to C¥1.71 in Q2 2025 and C¥1.13 in the latest quarter, highlighting how efficiently revenue may eventually translate into...

Capri Holdings (CPRI) just wrapped FY 2026 with Q4 revenue of US$796 million and a small loss, with basic EPS coming in at US$0.01, while on a trailing twelve month basis EPS was US$0.66 on revenue of US$3.5 billion. Over the past few quarters, revenue has moved between US$797 million and US$1.0 billion, with quarterly EPS ranging from a loss of US$0.28 to a profit of US$0.48, giving investors a mixed but improving read on profitability. Overall, the latest print points to tight margins and...